MCL-1 has previously been shown to be coexpressed with BIM across all subtypes of invasive breast carcinoma [14] and this expression pattern was recapitulated in our panel of human breast cancer cell lines. This evidence concerns the gene BCL2L11 and invasive breast carcinoma.